Dow Up 0.41% Nasdaq Down 0.01%

More On ARKTF

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

Ark Therapeutics Group plc (ARKTF)

-Other OTC
0.02 0.00(0.00%) Mar 5
Prev Close:0.02
Open:0.02
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:N/A
Volume:0
Avg Vol (3m):N/A
Market Cap:5.02M
P/E (ttm):2.67
EPS (ttm):0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ARKTF at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est () :N/A
Quarterly EPS Est () :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ark Therapeutics Group plc does not have significant operations. Prior to March 15, 2013, the company was engaged in the provision of contract development and manufacturing services to the pharmaceutical and biotech industry. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback